PharmiWeb.com - Global Pharma News & Resources
23-Jan-2019

Global Autism Report 2019: API Manufacturers, Marketed and Phase III Drugs Landscape, 2019-2021 - ResearchAndMarkets.com

The "Autism - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.

Autism - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019" report provides comprehensive insights about marketed and Phase III products for Autism . The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country.

Global API Manufacturers of Marketed Products for Autism

Coverage of API manufacturers for Autism marketed products spanning across United States, Europe, China and India. The manufacturers' details include manufacturers' name along with their location.

Emerging Phase III products for Autism

This report provides a comprehensive understanding of the emerging Phase III therapies for Autism which can turn out to be future prospective competitors for the marketed products. It will also put light on the current market trends. Their forecasted global sales are also provided till 2021.

Key Topics Covered:

1. Report Introduction

2. Autism: Overview

3. Comparative Analysis of Marketed and Emerging Products

4. Marketed Therapies

5. Emerging Therapies (Phase III)

Appendix

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/sv44w6/global_autism?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190123005363/en/

Editor Details

Last Updated: 23-Jan-2019